Matthew S McIlwain

NAUT

Matthew S McIlwain serves as Director at Nautilus Biotechnology, Inc. (NAUT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$814.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$814.9K

Companies Traded

NAUT

Active Period

Aug 2021 – Nov 2021

2 total trades

Most Recent

Buy NAUT

Nov 17, 2021 · $529.9K

Matthew S McIlwain's Insider Trading at Nautilus Biotechnology, Inc. (NAUT)

Buys

2 · $814.9K

Sells

0 · $0.00

Total Shares Bought

136,970

Total Shares Sold

NAUT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 17, 2021↗	Buy	100,000	$5.30	$529.9K	459,075
Aug 26, 2021↗	Buy	36,970	$7.71	$285.0K	359,075

Related Insiders

Sujal M Patel

director, 10 percent owner, officer: CEO, President, and Secretary

NAUTBuy · Mar 4, 2026

Matthew B. Murphy

General Counsel

NAUTBuy · Sep 4, 2025

Anna Mowry

CFO and Treasurer

NAUTBuy · May 29, 2025

Parag Mallick

Chief Scientist

NAUTBuy · May 12, 2025

Sujal M Patel

CEO, President, and Secretary

NAUTBuy · Mar 20, 2025

Explore More Insider Trading Data

NAUT Insider Trading Activity

View all insider trades at Nautilus Biotechnology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity